State Board Of Administration Of Florida Retirement System Intercept Pharmaceuticals, Inc. Transaction History

State Board Of Administration Of Florida Retirement System

$50.1 Billion
Q2 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$9.99 - $18.71 $115,644 - $216,586	11,576 New	11,576 $214,000
Q2 2022 Aug 05, 2022	SELL	$11.23 - $19.59 $51,433 - $89,722	-4,580 Reduced 24.48%	14,126 $195,000
Q2 2021 Aug 10, 2021	BUY	$15.46 - $24.5 $97,676 - $154,791	6,318 Added 51.0%	18,706 $374,000
Q1 2021 May 10, 2021	SELL	$19.33 - $37.75 $15,270 - $29,822	-790 Reduced 5.99%	12,388 $286,000
Q4 2020 Feb 08, 2021	SELL	$24.48 - $42.47 $17,625 - $30,578	-720 Reduced 5.18%	13,178 $325,000
Q3 2020 Nov 09, 2020	BUY	$39.09 - $53.44 $27,363 - $37,408	700 Added 5.3%	13,898 $576,000
Q2 2020 Aug 07, 2020	SELL	$46.7 - $92.04 $7,005 - $13,806	-150 Reduced 1.12%	13,198 $632,000
Q4 2019 Feb 03, 2020	SELL	$57.36 - $124.1 $35,563 - $76,942	-620 Reduced 4.44%	13,348 $1.65 Million
Q2 2019 Aug 05, 2019	BUY	$77.77 - $120.68 $193,647 - $300,493	2,490 Added 21.69%	13,968 $1.11 Million
Q1 2019 May 03, 2019	SELL	$91.83 - $120.68 $93,666 - $123,093	-1,020 Reduced 8.16%	11,478 $1.28 Million
Q2 2018 Aug 06, 2018	SELL	$60.0 - $85.67 $707,460 - $1.01 Million	-11,791 Reduced 48.54%	12,498 $1.05 Million
Q1 2018 May 04, 2018	SELL	$52.72 - $67.25 $65,003 - $82,919	-1,233 Reduced 4.83%	24,289 $1.49 Million
Q4 2017 Feb 01, 2018	SELL	$58.2 - $72.76 $43,359 - $54,206	-745 Reduced 2.84%	25,522 $1.49 Million
Q3 2017 Oct 31, 2017	BUY	$57.01 - $118.75 $1.5 Million - $3.12 Million	26,267	26,267 $1.53 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.

Account